 |
 |

Multiple Sclerosis: A Guide to Treatment and Management
5th ed, by Chris H. Polman, W. Ian McDonald, Alan J. Thompson, and
T. Jock Murray, 148 pp, $24.95, Demos Medical Publishing Inc, New York, NY,
2001.
Arch Neurol. 2002;59:1039-1040.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Writing a book in a quickly changing field becomes a difficult task
for an author. Within the last decade, the basic concepts of many neurological
diseases have changed rapidly. These changes have evolved through new knowledge
of the genetic code, greater understanding of immunological processes, and
novel research techniques. The integration of these factors has rapidly advanced
our knowledge of certain subjects and the science of neuroimmunology has been
at the forefront of these discoveries. Basic research into the complexities
involved, examination of immune defects in other autoimmune diseases, and
examination of the results of successful and unsuccessful treatment trials
have led to a greater depth of understanding of the immune system. Despite
all of these advances, the complete neuroimmunological picture evades us.
This is certainly true for multiple sclerosis (MS). Recent research into the
pathogenesis in MS has changed many of our perceptions of the disease and
changes in . . . [Full Text of this Article]
|